Hemorrhagic Fever, Ebola - 25 Studies Found
Completed |
: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) : Hemorrhagic Fever, Ebola : 2014-10-31 : Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5) |
Completed |
: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) : Hemorrhagic Fever, Ebola : 2015-02-19 : Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso |
Active, not recruiting |
: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda : Hemorrhagic Fever, Ebola : 2015-01-29 :
|
Recruiting |
: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo : Hemorrhagic Fever, Ebola : 2016-01-08 :
|
Recruiting |
: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo : Hemorrhagic Fever, Ebola : 2015-11-04 :
|
Completed |
: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea : Hemorrhagic Fever, Ebola : 2015-01-12 : Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
: Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects : Ebola : 2015-02-10 :
|
Recruiting |
: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults : Hemorrhagic Fever, Ebola : 2015-09-29 :
|
Active, not recruiting |
: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) : Ebola Virus : 2015-01-22 :
|
Recruiting |
: A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo :
: 2014-09-10 :
|